Phase 2 Gastric (Stomach) Cancer Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Breast CancerSarcomaLung Cancer+2 more
University of California, Irvine24 enrolled1 locationNCT07447050
Recruiting
Phase 1Phase 2
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Endometrial CancerGastric (Stomach) CancerNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Beijing Tide Pharmaceutical Co., Ltd266 enrolled3 locationsNCT07371663
Recruiting
Phase 1Phase 2
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Gastric (Stomach) CancerGastric AdenocarcinomaGEJ Adenocarcinoma+1 more
Henan Cancer Hospital45 enrolled1 locationNCT07334431
Recruiting
Phase 2
The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
Gastric (Stomach) CancerImmunotherapyBiological Therapy
Chinese PLA General Hospital90 enrolled1 locationNCT07212933
Recruiting
Phase 1Phase 2
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
Gastric (Stomach) CancerStomach Neoplasm
Asan Medical Center57 enrolled2 locationsNCT06732856
Recruiting
Phase 1Phase 2
XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
Gastric (Stomach) Cancer
West China Hospital57 enrolled2 locationsNCT06742411